Jina & Sons Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.40 M
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
- Revenue Growth 203.61%
- Profit Growth 85.48%
- Ebitda 142.42%
- Net Worth 31.01%
- Total Assets 49.73%
About Jina & Sons
Jina & Sons Private Limited (JSPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 July 2017 (Seven years and seven months 10 days old ). Its registered office is in Gorakhpur, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.40 M.
The company currently has active open charges totaling ₹4.00 M.
Nutan Jina and Radha Jina serve as directors at the Company.
Company Details
- Location
Gorakhpur, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85100UP2017PTC095088
- Company No.
095088
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jul 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Jina & Sons?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nutan Jina  | Director | 17-Jul-2017 | Current |
| Radha Jina | Director | 17-Jul-2017 | Current |
Financial Performance of Jina & Sons.
Jina & Sons Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 203.61% increase. The company also saw a substantial improvement in profitability, with a 85.48% increase in profit. The company's net worth Soared by an impressive increase of 31.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jina & Sons?
In 2020, Jina & Sons had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Arific Pharma Private LimitedNutan Jina is a mutual person
- City Medicity Private Limited
Nutan Jina is a mutual person
- Avarom Tradelink Private Limited
Radha Jina is a mutual person
Charges (Loans)
₹4.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 May 2023 | Axis Bank Limited | ₹4.00 M | Open |
How Many Employees Work at Jina & Sons?
Unlock and access historical data on people associated with Jina & Sons, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jina & Sons, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jina & Sons's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.